Cytoagents INC
At a glance
Employees1-19
In business sinceNot reported
HeadquartersAllegheny, PA
US patents1
SAM.gov UEICCEZCKNKL9M4
CAGE code8CQA6
Incorporated inDE
- treatment
- CTO1681
- pulmonary arterial hypertension
- atopic dermatitis
- inflammation
- tumor microenvironment
- dysregulated cytokine signaling
- immune hyperactivation
Named on the company’s own website, read JUL 29, 2026
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
1 US patent granted JUL 23, 2024.
Pharmaceuticals 1
- Compositions and methods for treating coronavirus infectionsUS 12,042,503 · granted JUL 23, 2024
Granted to CytoAgents, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Cytoagents INC | Allegheny | PA | 1–19 | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.